Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion type Assertion NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_head.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion description "[79.5% (62/78) of ovarian cancer samples proved to be PDGF-D positive, in contrast to just 38.5%(30/78) in their adjacent non-cancer tissues (p<0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_provenance.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion evidence source_evidence_literature NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_provenance.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion SIO_000772 22471482 NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_provenance.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion wasDerivedFrom befree-20140225 NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_provenance.
- NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_assertion wasGeneratedBy ECO_0000203 NP876062.RAnqz1gn_b64lsfF9Z6ofOiwPQb-46HKRGuEEbKN5Y-rk130_provenance.